Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-26T08:49:19.833Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical implications of restrictions in criteria for defining surgical site infections after mastectomy

Published online by Cambridge University Press:  17 November 2020

Antoinette A. A. Bediako-Bowan Open the ORCID record for Antoinette A. A. Bediako-Bowan [Opens in a new window] ,
David K. Warren Open the ORCID record for David K. Warren [Opens in a new window] ,
Katelin B. Nickel Open the ORCID record for Katelin B. Nickel [Opens in a new window] ,
Victoria J. Fraser Open the ORCID record for Victoria J. Fraser [Opens in a new window]  and
Margaret A. Olsen Open the ORCID record for Margaret A. Olsen [Opens in a new window]
Antoinette A. A. Bediako-Bowan
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri, United States Department of Surgery, University of Ghana, Accra, Ghana
David K. Warren
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri, United States
Katelin B. Nickel
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri, United States
Victoria J. Fraser
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri, United States
Margaret A. Olsen*
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri, United States Division of Public Health Sciences, Washington University School of Medicine, St Louis, Missouri, United States
*
Author for correspondence: Margaret A. Olsen, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

More than 50% of women with clinically apparent infection after mastectomy did not meet the 2020 National Healthcare Safety Network (NHSN) definition for surgical site infection (SSI). Implant loss was similar whether the 2020 NHSN SSI definition was met or not, suggesting equivalent adverse outcomes regardless of restriction to the surveillance definition.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 42 , Issue 6 , June 2021 , pp. 767 - 769
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370:1198–1208.CrossRefGoogle ScholarPubMed
Mangram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97–132.CrossRefGoogle Scholar
National Healthcare Safety Network (NHSN) procedure-associated (PA) module: surgical site infection (SSI) event. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf. Published 2019. Accessed June 17, 2019.Google Scholar
Nayyar, A, Reddy, KG, Strassle, PD, et al. Temporal trends in immediate post-mastectomy breast reconstruction. J Plast Reconstr Aesthet Surg 2019;72:513–527.CrossRefGoogle ScholarPubMed
Olsen, MA, Nickel, KB, Fox, IK, et al. Incidence of surgical site infection following mastectomy with and without immediate reconstruction using private insurer claims data. Infect Control Hosp Epidemiol 2015;36:907–914.CrossRefGoogle ScholarPubMed
Sharara, SL, Saunders, HM, Fabre, V, et al. Infection surveillance and prevention strategies to detect and prevent postaccess breast tissue expander infections. Infect Control Hosp Epidemiol 2019. doi: 10.1017/ice.2019.222.CrossRefGoogle Scholar
Kraenzlin, FS, Saunders, H, Aliu, O, et al. Classification of breast tissue expander infections: back to the basics. J Surg Oncol 2019;120:142–147.Google ScholarPubMed
Reish, RG, Damjanovic, B, Austen, WG Jr, et al. Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success. Plast Reconstr Surg 2013;131:1223–1230.CrossRefGoogle ScholarPubMed
Olsen, MA, Nickel, KB, Fox, IK, Margenthaler, JA, Wallace, AE, Fraser, VJ. Comparison of wound complications after immediate, delayed, and secondary breast reconstruction procedures. JAMA Surg 2017:e172338.CrossRefGoogle Scholar
Dicks, KV, Lewis, SS, Durkin, MJ, et al. Surveying the surveillance: surgical site infections excluded by the January 2013 updated surveillance definitions. Infect Control Hosp Epidemiol 2014;35:570–573.CrossRefGoogle ScholarPubMed
Supplementary material: File

Bediako-Bowan et al. supplementary material

Tables S1-S3

Download Bediako-Bowan et al. supplementary material(File)
File 21.3 KB